Difference between revisions of "Part:BBa K2610034"
Line 3: | Line 3: | ||
<partinfo>BBa_K2610034 short</partinfo> | <partinfo>BBa_K2610034 short</partinfo> | ||
− | This composite part features twice the regulatory part promoter SoxS ( | + | This composite part features twice the regulatory part promoter SoxS (BBa_K2610030) and the fluorescent protein GFP (BBa_E0040). It can be used to visualize upregulation of SoxS as a result of superoxide stress. |
Regulatory protein SoxS is involved in the superoxide pathway in Escherichia coli. It acts a superactivator of downstream stress genes. | Regulatory protein SoxS is involved in the superoxide pathway in Escherichia coli. It acts a superactivator of downstream stress genes. |
Revision as of 09:00, 10 October 2018
pSoxS-GFP-pSoxS-GFP
This composite part features twice the regulatory part promoter SoxS (BBa_K2610030) and the fluorescent protein GFP (BBa_E0040). It can be used to visualize upregulation of SoxS as a result of superoxide stress.
Regulatory protein SoxS is involved in the superoxide pathway in Escherichia coli. It acts a superactivator of downstream stress genes.
Usage and Biology
We, iGEM Leiden 2018, have designed this composite part as part of our project Fifty Shades of Stress. This reporter part allowed us to detect stress-induced changes in SoxS transcription. We have created this part in order to amplify the fluorescent signal measured after pSoxS-GFP activation.
As can be observed in Figure 1 the double promoter and GFP construct leads to an increased median fluorescence intensity compared to pSoxS-GFP. This activation was demonstrated through treatment of the transformed E.coli cells with nalidixic acid.
Figure 1. Median fluorescence intensity (MFI) as a result of treatment with nalidixic acid for three promoter-GFP constructs.
Moreover, we have demonstrated that our part is responsive to nalidixic acid in a dose-response manner (Figure 2). Concentrations higher than 1 ug/mL lead to death of the bacterial cells. Just before cell death occurs the fluorescence peaks.
Figure 2. Dose-response curve as a result of treatment with nalidixic acid.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 947
Illegal BsaI.rc site found at 1978